HOME >> BIOLOGY >> NEWS
Clinical trial patients don't care about study sponsors or physician conflicts of interest

Many patients will volunteer for a clinical trial if asked, even if the physician who inquires is a stockholder in the sponsoring company or has other potential conflicts of interest, a Johns Hopkins study demonstrates.

Results of the study, to be presented Nov. 11 at the American Heart Association's 76th annual Scientific Sessions in Orlando, Fla., also suggest that the majority of clinical trial patients don't care if their physician discloses such conflicts of interest to them.

"There's been an incredible push by academicians and health policy makers to make sure conflicts of interest are minimized," says Joel B. Braunstein, M.D., M.B.A., lead author of the study and an assistant professor of medicine at Hopkins. "While ethically, this is readily justified, our study quite surprisingly suggests that patients don't really care about these relationships. A patient's decision to enroll in a clinical trial involves many more factors, including interest in finding a new medication that might help him or her."

Braunstein and colleagues approached 1,132 patients from 13 Maryland-based cardiology and internal medicine outpatient clinics about participating in a hypothetical clinical trial for a new drug to help prevent heart attack. At random, they told patients that either there was no conflict of interest for the physician involved, the physician would receive a $2,000 finder's fee for each patient enrolled in the study, or the physician was a patent holder of the study drug. They also presented to patients one of three randomly assigned sponsors: a nonprofit research foundation, the U.S. government, or a pharmaceutical company.

Of the patients approached, 789 (70 percent) completed a questionnaire about clinical trial participation. About a third of all patients expressed interest in participation, whether or not there was a disclosed conflict of interest. More than half of the patients (55 percent) said they felt it was
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
11-Nov-2003


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Clinical judgement still counts strongly alongside genetic testing
3. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
4. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
5. DFG to establish seven new Clinical Research Units
6. NIH establishes Rare Diseases Clinical Research Network
7. Clinical study reports findings of combination therapy with DOXIL
8. Clinical study results published in NEJM show promising data on Antegren (natalizumab)
9. Clinical trial shows timing of chemotherapy improves survival in breast cancer
10. Clinical services must catch up
11. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... G5, the leader in ... performance up to 25% and reduces cost-per-click by as much as 15%. An ... attribution (MTA) to predict best advertising outcomes and automatically allocate daily ad investments ...
(Date:11/12/2019)... ... November 12, 2019 , ... Atlantic Ultraviolet Corporation ... today that distributors voted their patented automatic and manual wipers the #1 best ... The most frequent maintenance task required of an ultraviolet water purifier is quartz ...
(Date:11/9/2019)... ... ... SiteSeer Technologies, creator of SiteSeer Professional retail site selection software, is pleased ... The boutique real estate developer of single and multi-tenant buildings on sites ranging from ... analysis of markets. , Geoffrey Kerth, manager of GPK Acquisitions, says that his ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... leaders through off-the-record collaboration and dialogue, today announces its East/West CEO ... in San Francisco. , Kicking off the week of the ...
(Date:11/5/2019)... ... , ... Ole, a German Shepherd, was demonstrating signs of osteoarthritis in April 2019. He ... level and his willingness to play were normal, it was clear that he was in ... Emergency Animal Hospital and Referral Center in San Diego, California. Dr. Mullen is ...
(Date:11/2/2019)... , ... October 31, 2019 , ... ... by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in biomedical ... tool allows researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, and ...
Breaking Biology Technology:
Cached News: